Kristian F. Humer
Chief Accounting Officer
Foghorn Therapeutics Inc. (FHTX)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Kristian F. Humer
Kristian F. Humer is recorded as CFO and Chief Accounting Officer at Foghorn Therapeutics Inc. (FHTX). Foghorn Therapeutics Inc. reported in an 8-K filed April 16, 2024 that Kristian F. Humer was appointed Chief Financial Officer, effective April 16, 2024.
“On April 16, 2024, Foghorn Therapeutics Inc. (the "Company") announced that Kristian F. Humer had been appointed to serve as the Company's Chief Financial Officer, effective immediately.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2024-04-16–present
-
Current
2024-04-16–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Foghorn Therapeutics Inc.
Other people whose current roles at this company are on record from its filings.
- Adrian Gottschalk CEO, Board Member
- Jeff Sacher CFO
- Ryan D. Maynard CFO
- Ryan Maynard CFO
- Stephen J. DiPalma CFO
- Steven Bellon CTO
- B. Lynne Parshall Board Member
- Ian F. Smith Board Member
- Neil J. Gallagher, M.D., Ph.D. Board Member
- Stuart Duty Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.